Cipla Says Eight Observations By U.S. FDA For Goa Unit Are Procedural

Cipla received eight observations regarding manufacturing practices at its Goa plant.

General views of drugs (Photographer: Brent Lewin/Bloomberg)

Cipla Ltd. received eight observations regarding manufacturing practices at its Goa plant that contributes a quarter of the drugmaker’s sales in the U.S.

Also Read: Why Investors Are Betting On MNCs Over Homegrown Drugmakers

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google